Joon-Yong Chung

44PUBLICATIONS
128CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Micro- and nanosystemsNutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (44)

|Sep 09, 2026
Glypican-3-Targeted Paired Radiotheranostics in Orthotopic Liver Cancer Models.

|Aug 22, 2026
Prognostic Significance and Functional Role of PPIB in a Retrospective Cohort of Patients with Advanced Gastric Cancer.

|Jul 28, 2026
Prognostic Value of Exportin-7 and Its Association with KRAS Status and Autophagy Markers in Small Intestinal Adenocarcinoma.

|Jul 01, 2026
Species-specific regulation of necroptosis by STK38-dependent RIPK1 phosphorylation.

|May 25, 2026
Ablation of glypican-3 enhances radiosensitivity in liver cancer by prolonging G2/M arrest and activating the ATM/CHK2 pathway.

|Dec 19, 2025
Coffee Consumption and Colorectal Cancer Survival: A Dose-Response Meta-analysis by Coffee Type and Disease Stage.

Jun-Yeol Kim, Yu-Jin Choi, Yo-Chan Ahn

Pageof 8

Frequent Collaborators

10 joint publications

Stephen M Hewitt

6 joint publications

Freddy E Escorcia

5 joint publications

Jaewhan Song

5 joint publications

Hanbyoul Cho